Flexible device portfolio Apollo is not tethered to a single manufacturer, evaluating products on clinical efficacy, patient experience, and ROI. This enables tailoring a multi-device solution for clinics' needs and ROI targets, creating cross-sell opportunities across aesthetic modalities.

ROI focused value Their value proposition centers on reducing patient acquisition costs and boosting patient lifetime value through innovative products and services. This provides a strong hook for clinics prioritizing CAC/LTV, with opportunities for joint marketing and ROI case studies.

Growth partnerships Recent leadership expansion and ongoing training events signal growth and openness to channel partnerships. Consider a formal channel partner program with co-marketing, sales enablement, and training to accelerate device adoption.

Strategic collaborations Past deals with CryoXcel and COVID-19 testing programs show willingness to collaborate with manufacturers and expand product lines. This points to potential for on-boarding additional device makers or exclusive distribution arrangements.

Regional scaling Headquartered near Atlanta with training activity across Cleveland, Dallas, and Atlanta indicates regional reach and growth potential. Opportunities include regional distribution agreements, localized marketing campaigns, and logistics support to scale adoption.